QGMS
1.416 QAR
-1.26%
Today
-1.26%
1D
Market is closed
Sun
9:30 AM ~ 1:00 PM
Mon
9:30 AM ~ 1:00 PM
Tue
9:30 AM ~ 1:00 PM
Wed
9:30 AM ~ 1:00 PM
Thu
9:30 AM ~ 1:00 PM
Fri
Closed
Sat
Closed
Information
Name
QG Medical Devices
Currency
QAR
Standard Leverage
1X
Market Cap
155.81M
Avg Daily Volume
3.68M
52 Week High
1.787 QAR
52 Week Low
1.216 QAR
Trading Hours
See hours
Business Summary
Qatari German Company for Medical Devices (Q.P.S.C.) manufactures and sells single use disposable syringes in Qatar and internationally. It offers Q JectUltra, an insulin syringe serving as a tool in diabetic care; Q Flow for infusion therapy; Q Need, a single use hypodermic needle; Q Ject, a single use syringe for the curative medications; and Q Safe, a re-use prevention syringe. The company also trades in medical consumables, equipment, tools and supplies, and furniture. In addition, it provides healthcare training. The company was incorporated in 2000 and is headquartered in Doha, Qatar.
Top News
UNG_CFD
-0.56%
EQT_Corp
-1.26%
USO_CFD
-1.73%
Sector Update: Energy Stocks Lean Lower Premarket Friday
finance.yahoo.com
17h ago
GLD_CFD
-0.18%
DXY
-0.19%
XAUUSD
-0.34%
Gold Trading Lower as U.S. Inflation Surged in March on Higher Gasoline Prices
finance.yahoo.com
17h ago
USO_CFD
-1.73%
Oil Edges Lower Amid a Shaky Ceasefire Between the U.S. and Iran as Israel Continues to Attack Lebanon
finance.yahoo.com
17h ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
